Personalizing therapy for older adults with lymphoid malignancies: Options and obstacles Journal Article


Authors: Wildes, T. M.; Goede, V.; Hamlin, P.
Article Title: Personalizing therapy for older adults with lymphoid malignancies: Options and obstacles
Abstract: Increasing age is both a risk factor for and a negative prognostic factor in lymphoid malignancies. The disparities in outcomes between older and younger adults with lymphoid malignancies may reflect age-related differences in treatment and in biology of disease. Lymphomas in older adults are biologically more aggressive. Only small age-related differences in the frequency of cytogenetic abnormalities are seen in multiple myeloma. No major differences in the biology of chronic lymphocytic leukemia (CCL) are seen across the age spectrum. Chemotherapy and immunotherapy in older adults with lymphoid malignancies are marked by greater vulnerability to toxicity of therapy. Excessive toxicity can result in poorer outcomes, either directly through treatment-related mortality, or through decreased dose intensity. Thus, new approaches to predict toxicity of therapy and stratified treatment algorithms based on risk of toxicity are needed. Herein we detail some of the promising approaches to predicting toxicity and tailoring treatment for older adults with lymphoid malignancies.
Keywords: treatment outcome; aged; aged, 80 and over; antineoplastic agents; antineoplastic agent; multiple myeloma; immunotherapy; lymphoma; leukemia, lymphocytic, chronic, b-cell; personalized medicine; adverse effects; individualized medicine; procedures; very elderly; humans; human
Journal Title: American Society of Clinical Oncology Educational Book
Volume: 34
ISSN: 1548-8756
Publisher: American Society of Clinical Oncology  
Date Published: 2014-01-01
Start Page: e240
End Page: e248
Language: English
DOI: 10.14694/EdBook_AM.2014.34.e240
PUBMED: 24857108
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 7 January 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Hamlin
    277 Hamlin